Citi Pharma Ltd. Discloses Financial Results for Jan-Oct 2023

Karachi: Citi Pharma Ltd.XD NC (Symbol Code: CPHL) marked a today’s rate of Rs. 22.96 and a daily weighted average rate of Rs. 23.04. The company’s paid-up capital is Rs. 2,284.61 million. Ending its financial year in June, Citi Pharma announced distributions of 15%10%B for 2021, with no distribution for 2022 and 25% for 2023. The par value is Rs. 10, with a market lot of one. The company’s previous book closure was on 20/10. Citi Pharma was listed in 2021. Between January and October 2023, the high rate was Rs. 29.45, the low was Rs. 19.07, and the turnover amounted to 171,246,231. The EPS for 2021/2022 is Rs. 2.61.

Check Also

Pakistan Ready to Collaborate for Democratic UNSC, Says Ambassador Asim

New york: Pakistan stands ready to work with Africa and all partners for a just, democratic, and representative Security Council, truly reflective of the Charter's promise and responsive to the realities of our time. This was stated by the Permanent R...